The Student Global AIDS Campaign (SGAC) is applauding what it calls “important steps forward and major new promises” taken by Gilead in making its AIDS drugs Tenofovir (Viread) and Truvada affordable and available in Africa and the global South. The Student Global AIDS Campaign—a national network of AIDS activists in high schools and colleges—has been running a campaign focused on Gilead since this winter.